Skip to content

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00474734
Enrollment
Unknown
Registered
2007-05-17
Start date
2007-05-31
Completion date
2007-09-30
Last updated
2007-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

hepatocellular carcinoma, liver transplantation, staging, intravascular ultrasound

Brief summary

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm. Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential. As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.

Interventions

DEVICEIntravascular ultrasound of the liver

Sponsors

University Hospital, Geneva
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* hepatocellular carcinoma nodules * patient on liver transplantation waiting list * written informed consent

Exclusion criteria

* thrombosis of hepatic veins or vena cava

Countries

Switzerland

Contacts

Primary ContactAntoine Hadengue, Prof.
antoine.hadengue@hcuge.ch+41 22 37 29 340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026